CURRENT STRATEGY FOR THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME IN NEWBORNS (literature review)
Abstract
Respiratory distress syndrome (P22.0; ICD-10) is a condition associated with lung immaturity and surfactant deficiency in neonates born prematurely. Treatment of RDS remains a key component of neonatal intensive care. The aim of the study was to analyze current treatment strategies for neonatal respiratory distress syndrome. Materials and methods of the study: scientific literature and methodological recommendations of foreign and domestic authors of recent years were analyzed. Study results: the prognosis for newborns who have received prenatal steroids, respiratory support, and exogenous surfactant therapy is favorable. Mortality is less than 10%, and in some studies, survival rates reach 98% when using advanced treatment methods. The evidence base for the updated recommendations and the emergence of some new positions require the implementation of a national protocol for the management of newborns with RDS, which will improve the quality of medical care for newborns and reduce mortality rates among premature infants and severe complications.